Preview: Neumora Therapeutics, Inc Set To IPO Tomorrow

Neumora Therapeutics, Inc NMRA IPO will take place September, 15 on the NASDAQ exchange under the ticker NMRA.

The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 13, 2024.

See also: Benzinga IPO Calendar

About Neumora Therapeutics, Inc

Neumora Therapeutics, Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.